Seqirus

Seqirus is one of the largest influenza vaccine companies in the world. Seqirus was created after its parent company, CSL Limited, acquired Novartis' influenza vaccine business and merged it with its vaccine subsidiary, bioCSL. At Seqirus, there is only one goal: to reduce the severity and impact of influenza, which can reach epidemic or even pandemic levels and pose life-threatening risks. Each year, Seqirus' influenza vaccines help protect millions of people. They find solutions to large, complex, and challenging problems, and the results can be seen in the world around them.